Shares of Omega Healthcare Investors, Inc. (NYSE:OHI) have received a consensus recommendation of “Hold” from the eight ratings firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, four have given a hold recommendation and one has assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have issued ratings on the stock in the last year is $33.59.

A number of equities research analysts have commented on the company. Jefferies Group LLC reissued a “hold” rating and issued a $33.00 target price on shares of Omega Healthcare Investors in a report on Friday, May 12th. Zacks Investment Research downgraded Omega Healthcare Investors from a “buy” rating to a “hold” rating in a report on Tuesday, February 21st. Finally, Vetr downgraded Omega Healthcare Investors from a “hold” rating to a “sell” rating and set a $32.50 target price for the company. in a report on Monday, April 17th.

Shares of Omega Healthcare Investors (NYSE OHI) traded down 0.1494% during midday trading on Monday, reaching $32.8808. 218,429 shares of the company traded hands. The stock has a market capitalization of $6.47 billion, a P/E ratio of 15.4153 and a beta of 0.55. The stock’s 50-day moving average is $32.36 and its 200-day moving average is $32.14. Omega Healthcare Investors has a 1-year low of $28.11 and a 1-year high of $38.09.

Omega Healthcare Investors (NYSE:OHI) last released its earnings results on Wednesday, May 3rd. The real estate investment trust reported $0.88 EPS for the quarter, beating analysts’ consensus estimates of $0.86 by $0.02. Omega Healthcare Investors had a return on equity of 9.95% and a net margin of 45.16%. The company had revenue of $231.74 million during the quarter, compared to the consensus estimate of $197.55 million. During the same quarter last year, the company earned $0.83 earnings per share. Omega Healthcare Investors’s quarterly revenue was up 8.9% compared to the same quarter last year. Equities analysts predict that Omega Healthcare Investors will post $1.99 EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This piece was originally posted by American Banking News and is owned by of American Banking News. If you are viewing this piece on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/06/19/omega-healthcare-investors-inc-ohi-receives-average-rating-of-hold-from-analysts.html.

In other news, insider Steven J. Insoft sold 87,500 shares of the firm’s stock in a transaction on Tuesday, April 11th. The stock was sold at an average price of $34.00, for a total value of $2,975,000.00. Following the completion of the transaction, the insider now owns 324,076 shares in the company, valued at $11,018,584. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Craig R. Callen purchased 15,000 shares of the company’s stock in a transaction dated Friday, June 2nd. The stock was purchased at an average price of $31.40 per share, with a total value of $471,000.00. Following the transaction, the director now owns 18,000 shares of the company’s stock, valued at $565,200. The disclosure for this purchase can be found here. Company insiders own 4.54% of the company’s stock.

Several hedge funds and other institutional investors have recently made changes to their positions in OHI. Vanguard Group Inc. boosted its position in shares of Omega Healthcare Investors by 4.6% in the first quarter. Vanguard Group Inc. now owns 31,762,511 shares of the real estate investment trust’s stock worth $1,047,845,000 after buying an additional 1,397,206 shares in the last quarter. BlackRock Inc. boosted its position in shares of Omega Healthcare Investors by 4,872.8% in the first quarter. BlackRock Inc. now owns 19,889,913 shares of the real estate investment trust’s stock worth $656,169,000 after buying an additional 19,489,938 shares in the last quarter. State Street Corp boosted its position in shares of Omega Healthcare Investors by 2.5% in the first quarter. State Street Corp now owns 6,020,950 shares of the real estate investment trust’s stock worth $198,623,000 after buying an additional 147,637 shares in the last quarter. Bank of New York Mellon Corp boosted its position in shares of Omega Healthcare Investors by 1.7% in the first quarter. Bank of New York Mellon Corp now owns 4,072,873 shares of the real estate investment trust’s stock worth $134,365,000 after buying an additional 67,809 shares in the last quarter. Finally, Morgan Stanley boosted its position in shares of Omega Healthcare Investors by 1.6% in the first quarter. Morgan Stanley now owns 3,687,995 shares of the real estate investment trust’s stock worth $121,667,000 after buying an additional 59,077 shares in the last quarter. Institutional investors and hedge funds own 75.67% of the company’s stock.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.